Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.

ABSTRACT: Immunotherapies such as immune checkpoint blockade benefit only a portion of patients with head and neck squamous cell carcinoma. The multidisciplinary field of nanomedicine is emerging as a promising strategy to achieve maximal anti-tumor effect in cancer immunotherapy and to turn non-responders into responders. Various methods have been developed to deliver therapeutic agents that can overcome bio-barriers, improve therapeutic delivery into the tumor and lymphoid tissues and reduce adverse effects in normal tissues. Additional modification strategies also have been employed to improve targeting and boost cytotoxic T cell-based immune responses. Here, we review the state-of-the-art use of nanotechnologies in the laboratory, in advanced preclinical phases as well as those running through c

SUBMITTER: Xu Q 

PROVIDER: S-EPMC7415431 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature